Cogent Biosciences, INC. (COGT) — DEF 14A Filings
All DEF 14A filings from Cogent Biosciences, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Cogent Biosciences DEF 14A: Executive Compensation Details
— Apr 22, 2025 Risk: low
Cogent Biosciences, Inc. filed its DEF 14A on April 22, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes -
Cogent Biosciences Announces 2024 Annual Meeting of Stockholders on June 5
— Apr 23, 2024 Risk: low
Cogent Biosciences, Inc. (COGT) filed a Proxy Statement (DEF 14A) with the SEC on April 23, 2024. Cogent Biosciences will hold its 2024 Annual Meeting of Stockh
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX